Pharming Group N.V. (AMS:PHARM)
1.432
-0.033 (-2.25%)
At close: Dec 15, 2025
Pharming Group Revenue
Pharming Group had revenue of $97.30M USD in the quarter ending September 30, 2025, with 30.00% growth. In the year 2024, Pharming Group had annual revenue of $297.20M with 21.15% growth.
Revenue
$297.20M
Revenue Growth
+21.15%
P/S Ratio
3.25
Revenue / Employee
$735.64K
Employees
404
Market Cap
1.00B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 297.20M | 51.88M | 21.15% |
| Dec 31, 2023 | 245.32M | 39.69M | 19.30% |
| Dec 31, 2022 | 205.62M | 6.75M | 3.39% |
| Dec 31, 2021 | 198.87M | -13.30M | -6.27% |
| Dec 31, 2020 | 212.17M | 22.53M | 11.88% |
| Dec 31, 2019 | 189.64M | 34.36M | 22.12% |
| Dec 31, 2018 | 155.29M | 47.75M | 44.40% |
| Dec 31, 2017 | 107.54M | 90.83M | 543.88% |
| Dec 31, 2016 | 16.70M | 4.94M | 42.05% |
| Dec 31, 2015 | 11.76M | -13.88M | -54.13% |
| Dec 31, 2014 | 25.63M | 16.22M | 172.36% |
| Dec 31, 2013 | 9.41M | -4.59M | -32.77% |
| Dec 31, 2012 | 14.00M | 10.12M | 260.60% |
| Dec 31, 2011 | 3.88M | 2.41M | 163.98% |
| Dec 31, 2010 | 1.47M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionPharming Group News
- 7 days ago - Pharming Group to participate in Oppenheimer Movers in Rare Disease Summit - GlobeNewsWire
- 19 days ago - Wall Street Analysts Believe Pharming Group (PHAR) Could Rally 81.71%: Here's is How to Trade - Nasdaq
- 26 days ago - Pharming Group N.V. (PHAR) Presents at Jefferies London Healthcare Conference 2025 - Slideshow - Seeking Alpha
- 4 weeks ago - Pharming Group Posts Upbeat Q3 Results, Joins On Holding, BigBear.ai Holdings And Other Big Stocks Moving Higher On Wednesday - Benzinga
- 5 weeks ago - Earnings Estimates Moving Higher for Pharming Group (PHAR): Time to Buy? - Nasdaq
- 5 weeks ago - Pharming Group N.V. (PHAR) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Pharming Group (PHGUF) Q3 2025 Earnings Call Highlights: Revenue Surge and Strategic Adjustments - GuruFocus
- 5 weeks ago - Q3 2025 Pharming Group NV Earnings Call Transcript - GuruFocus